Global Heart
| 短名 | gh |
| Journal Impact | 3.19 |
| 国际分区 | CARDIAC & CARDIOVASCULAR SYSTEMS(Q2) |
| 期刊索引 | SCI Q2中科院 3 区 |
| ISSN | 2211-8160, 2211-8179 |
| h-index | 50 |
| 国内分区 | 医学(3区)医学心脏和心血管系统(3区) |
GLOBAL HEART 为全球心血管疾病 (CVD) 预防和控制相关的研究、发展、趋势、解决方案和公共卫生计划提供对话和教育论坛，特别关注低收入和中等收入国家 (LMIC) .手稿不仅应说明问题的程度或流行病学，还应描述有效控制和预防 CVD 及其潜在因素的干预措施。重点应放在适用于资源有限环境的方法上。对成功干预的经济评价尤其受欢迎。如果重要的话，我们也会考虑负面的发现。虽然不排除医院或诊所治疗的报告，特别是如果它们对具有成本效益的疾病控制或预防具有广泛影响，我们优先考虑解决基于社区的活动的论文。我们鼓励提交心血管监测和健康政策、专业教育、伦理问题和与预防相关的技术创新。全球心脏特别有兴趣发布来自更新的国家或地区人口健康调查、世界卫生组织或全球疾病负担数据的数据，大临床疾病数据库或登记。欢迎对全球相关主题进行系统评价或荟萃分析。我们还将考虑与 LMIC 特别相关的临床研究，例如使用经过验证的仪器来评估 LMIC 患者的健康相关生活质量、创新的诊断治疗应用、真实世界有效性临床试验、研究方法（创新方法学论文，重点是低成本研究方法或新的应用资源匮乏环境中的方法），以及与心血管健康促进和政策有关的论文（健康计划的定量评估。
期刊主页投稿网址| 涉及主题 | 医学内科学心脏病学生物病理心理学精神科外科内分泌学放射科 |
| 出版信息 | 出版商: Elsevier Science & Technology，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2011，原创研究文献占比: 81.93%，自引率:3.30%， Gold OA占比: 98.65% |
| 平均审稿周期 | 网友分享经验：5 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Use of Guideline-Recommended Heart Failure Drugs in High-, Middle-, and Low-Income Countries: A Systematic Review and Meta-Analysis
2024-9-12
A Cross-Sectional Survey of Fixed-Dose Combination Antihypertensive Medicine Prescribing in Twenty-Four Countries, Including Qualitative Insights
2024-9-12
Gender Differential Prevalence of Overweight and Obesity, Hypertension and Diabetes in South India: A Population-Based Cross-Sectional Study
2024-9-9
Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in India: A Convergent Parallel Mixed Methods Study
2024-8-26
Hypertension Prevalence among Hispanics/Latinos of Dominican Background: A Transnational Comparison of HCHS/SOL and ENPREFAR-HAS-17
2024-8-26
Use of Cardiovascular Disease Secondary Prevention Medications in Four Middle East Countries in a Community Setting
2024-8-26
Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya
2024-8-16
Lipid Control and Medical Costs Among Patients With and Without Established Atherosclerotic Cardiovascular Disease Followed in a Brazilian Private Healthcare System
2024-8-14
Bayesian Modeling and Estimation of Spatial Risk for Hospitalization and Mortality from Ischemic Heart Disease in Paraná, Brazil
2024-8-5
Effectiveness of the Hypertension Screening Corner in Enhancing the Cascade of Care at Primary Healthcare Center Level: Evidence from Zambezia, Mozambique
2024-7-10
Long-Term Outcomes of Sex Differences in Three-Vessel Coronary Disease with Different Treatment Strategies: A Large Cohort Study
2024-7-3
Causal Associations of Environmental Pollution and Cardiovascular Disease: A Two-Sample Mendelian Randomization Study
2024-6-18
The Prevalence and Epidemiological Features of Ischaemic Heart Disease in Sri Lanka
2024-6-3
Causal Associations of DNA Methylation and Cardiovascular Disease: A Two-Sample Mendelian Randomization Study
2024-5-14
The Association of Micro-RNA 21 and Hypertension: A Meta-Analysis
2024-5-1
Routine Antenatal Echocardiography in High-Prevalence Areas of Rheumatic Heart Disease: A WHO-Guideline Systematic Review
2024-4-25
The Average Age of Atrioventricular Block Onset in Middle Eastern Patients with Cardiac Rhythm Devices Adjusted for the Overall Young Population: Insights from a Multicenter International Registry
2024-4-25
Long-Term Effects of Opium Consumption Following Percutaneous Coronary Intervention: A 10-year Follow-Up Study
2024-4-24
Cardiovascular Outcomes Among Patients with Acute Coronary Syndromes and Diabetes: Results from ACS QUIK Trial in India
2024-4-24
Quality of Life in Ugandan Children and Young Adults After Surgery for Congenital Heart Disease: Mixed Methods Approach
2024-4-17
Health Facilities Readiness and Determinants to Manage Cardiovascular Disease in Afghanistan, Bangladesh, and Nepal: Evidence from the National Service Provision Assessment Survey
2024-3-20
India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022
2024-3-19
Association of Pre-PCI Blood Pressure and No-Reflow in Patients with Acute ST-Elevation Coronary Infarction
2024-3-4
Association Between Myocardial Infarction and Triglyceride-Glucose Index: A Study Based on NHANES Database
2024-2-23
Prevalence of Cardiovascular Disease and Risk Factors in Ghana: A Systematic Review and Meta-analysis
2024-2-20
Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping Review
2024-2-20
Heartache and Heartbreak: An Observational and Mendelian Randomization Study
2024-2-16
Sex Differences in Cardiovascular Disease Risk Factor Prevalence, Morbidity, and Mortality in Colombia: Findings from the Prospective Urban Rural Epidemiology (PURE) Study
2024-1-24
Sex Differences in the Primary Prevention of Cardiovascular Diseases in a Dutch Primary Care Setting
2024-1-19
New Insights into Rate Control: Time in Target Range of Resting Heart Rate and Major Adverse Outcomes in Atrial Fibrillation
2024-1-11
Atherosclerotic Cardiovascular Disease Novel and Traditional Risk Factors in Middle Eastern Young Women. The ANCORS-YW Study
2024-1-1
The Prognostic Value of Serum Calcium Levels in Elderly Dilated Cardiomyopathy Patients
2024-1-1
Updated 2022 ACC/AHA Guideline Improves Concordance Between TTE and CT in Monitoring Marfan Snydrome and Related Disorders, but Relevant Measurement Differences Remain Frequent
2024-1-1
Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
2024-1-1
Stroke Care in South Asia – Identifying Gaps for Future Action
2024-1-1
Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data
2024-1-1
Manifestations of Rheumatic Carditis, Regression of Valvular Regurgitation, and Independent Predictors of Mitral Regurgitation Improvement After Rheumatic Carditis in Thai Children
2024-1-1
Characterization of Non-Ischemic Dilated Cardiomyopathy in a Native Tanzanian Cohort: MOYO Study
2024-1-1
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension
2024-1-1
Nicotine and Cardiovascular Health: When Poison is Addictive – a WHF Policy Brief
2024-1-1
Inclusion of Polypills for Prevention of Cardiovascular Disease in the 23rd World Health Organization Model List of Essential Medicines: A Significant Step Towards Reducing Global Cardiovascular Morbidity and Mortality
2024-1-1
Spectrum of Heart Diseases in Children in a National Cardiac Referral Center Tanzania, Eastern Africa: A Six-Year Overview
2024-1-1
Task Sharing and Task Shifting (TSTS) in the Management of Africans with Hypertension: A Call For Action-Possibilities and Its Challenges
2024-1-1
Evaluating the Effectiveness of African School of Hypertension for Non-Physician Health Workers, a Qualitative Study: QuASH Hypertension Study
2024-1-1
Toward a Better Understanding of Cardiovascular Risk in the Transgender and Gender-Diverse Community: A Global Call to Action
2024-1-1
International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia
2024-1-1
Mortality in Women with Coronary Artery Disease in Paraná State, Brazil: A Bayesian Spatiotemporal Analysis
2024-1-1
A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
2024-1-1
Greater Disease Severity and Worse Clinical Outcomes in Patients Hospitalised with COVID-19 in Africa
2024-1-1
Prevalence and Clustering of Cardiovascular Disease Risk Factors among Adults Along the Lancang-Mekong River: A Cross-Sectional Study from Low- and Middle-Income Countries
2024-1-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远